Fluoroestradiol F 18 + Fulvestrant Interaction
Majorinteraction on record
Description
Binds to estrogen receptor and competes with fluoroestradiol F 18, reducing detection of ER-positive lesions. Discontinue for at least 28 weeks before administering CERIANNA.
Mechanism
Competition for estrogen receptor binding
Source: NLP:fluoroestradiol f 18